Details for New Drug Application (NDA): 088101
✉ Email this page to a colleague
NDA 088101 describes NAFAZAIR, which is a drug marketed by Bausch And Lomb and Pharmafair and is included in two NDAs. Additional details are available on the NAFAZAIR profile page.
The generic ingredient in NAFAZAIR is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
The generic ingredient in NAFAZAIR is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
Summary for 088101
| Tradename: | NAFAZAIR |
| Applicant: | Pharmafair |
| Ingredient: | naphazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088101
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Apr 15, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
